Literature DB >> 21406312

Characterization of myofibroblasts in chronic thromboembolic pulmonary hypertension.

Miki Maruoka1, Seiichiro Sakao, Masashi Kantake, Nobuhiro Tanabe, Yasunori Kasahara, Katsushi Kurosu, Yuichi Takiguchi, Masahisa Masuda, Ichiro Yoshino, Norbert F Voelkel, Koichiro Tatsumi.   

Abstract

BACKGROUND: It has been generally accepted that chronic thromboembolic pulmonary hypertension (CTEPH) results from pulmonary embolism arising from deep vein thrombosis. An unresolved question regarding the etiology of CTEPH is why pulmonary thromboemboli are stable and resistant to effective anticoagulation. Recently non-resolving pulmonary thromboemboli in CTEPH have been shown to include myofibroblasts. This study investigates the cellular characteristics of myofibroblasts included in the organized thrombotic tissues of CTEPH.
METHODS: Organized thrombotic tissues of patients with CTEPH were obtained following pulmonary endarterectomy. We isolated cells from endarterectomized tissue from patients with CTEPH and identified them as endothelial-like cells and myofibroblast-like cells.
RESULTS: Myofibroblast-like cells were characterized as hyperproliferative, anchorage-independent, invasive and serum-independent.
CONCLUSIONS: Here we report the presence of active myofibroblast-like cells in endarterectomized tissue of CTEPH. We suggest that the formation of myofibroblasts with a high growth potential in the organized thrombotic tissues may be an important event in the pathobiology of this disease.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21406312     DOI: 10.1016/j.ijcard.2011.02.037

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

Review 1.  Inflammation in Pulmonary Arterial Hypertension.

Authors:  Timothy Klouda; Ke Yuan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Chronic Thromboembolic Pulmonary Hypertension: the Bench.

Authors:  George A Alba; Deepak Atri; Sriranjani Darbha; Inderjit Singh; Victor F Tapson; Michael I Lewis; Hyung J Chun; Yen-Rei Yu; Bradley A Maron; Sudarshan Rajagopal
Journal:  Curr Cardiol Rep       Date:  2021-08-19       Impact factor: 2.931

3.  The role of β-catenin in pulmonary artery endothelial-mesenchymal transformation in rats with chronic thromboembolic pulmonary hypertension.

Authors:  Meie Zeng; Shimou Chen; Hongli Li; Zhigui Huang; Dawen Wu; Yunchang Pan; Chaosheng Deng
Journal:  J Thromb Thrombolysis       Date:  2021-03-02       Impact factor: 2.300

4.  Endothelial-like cells in chronic thromboembolic pulmonary hypertension: crosstalk with myofibroblast-like cells.

Authors:  Seiichiro Sakao; Hiroyuki Hao; Nobuhiro Tanabe; Yasunori Kasahara; Katsushi Kurosu; Koichiro Tatsumi
Journal:  Respir Res       Date:  2011-08-22

5.  Inflammatory response and pneumocyte apoptosis during lung ischemia-reperfusion injury in an experimental pulmonary thromboembolism model.

Authors:  Chaosheng Deng; Zhenguo Zhai; Dawen Wu; Qichang Lin; Yuanhua Yang; Minxia Yang; Haibo Ding; Xiaoming Cao; Qiaoxian Zhang; Chen Wang
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

6.  The role of matrix metalloproteinase in the intimal sarcoma-like cells derived from endarterectomized tissues from a chronic thromboembolic pulmonary hypertension patient.

Authors:  Takayuki Jujo; Seiichiro Sakao; Masanori Tsukahara; Masashi Kantake; Seiji Kantake; Miki Maruoka; Nobuhiro Tanabe; Masahisa Masuda; Koichiro Tatsumi
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

7.  Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH.

Authors:  Bernhard Moser; Anna Megerle; Christine Bekos; Stefan Janik; Tamás Szerafin; Peter Birner; Ana-Iris Schiefer; Michael Mildner; Irene Lang; Nika Skoro-Sajer; Roela Sadushi-Kolici; Shahrokh Taghavi; Walter Klepetko; Hendrik Jan Ankersmit
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

8.  Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction.

Authors:  Diana Zabini; Chandran Nagaraj; Elvira Stacher; Irene M Lang; Patrick Nierlich; Walter Klepetko; Akos Heinemann; Horst Olschewski; Zoltán Bálint; Andrea Olschewski
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

9.  Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance.

Authors:  Takayuki Jujo; Seiichiro Sakao; Hatsue Ishibashi-Ueda; Keiichi Ishida; Akira Naito; Toshihiko Sugiura; Ayako Shigeta; Nobuhiro Tanabe; Masahisa Masuda; Koichiro Tatsumi
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

10.  Beneficial effects of inhaled NO on apoptotic pneumocytes in pulmonary thromboembolism model.

Authors:  Chaosheng Deng; Minxia Yang; Qichang Lin; Yuanhua Yang; Zhenguo Zhai; Kaixiong Liu; Haibo Ding; Xiaoming Cao; Zhihua Huang; Lina Zhang; Jianming Zhao
Journal:  Theor Biol Med Model       Date:  2014-08-10       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.